Evidence map›Paper›PMID 33648591›Full record

ArticleActa neuropathologica communications2021

Neuronal hibernation following hippocampal demyelination.

Selva Baltan, Safdar S Jawaid, Anthony M Chomyk, Grahame J Kidd, Jacqueline Chen, Harsha D Battapady, Ricky Chan, Ranjan Dutta, Bruce D Trapp

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Astrocytes: Lessons Learned from the Cuprizone Model.International journal of molecular sciences · 2023
    Review
  9. Roles of Adenosine Receptor (subtypes AMolecular neurobiology · 2023
    Article
  10. Article
  11. Structural Plasticity of the Hippocampus in Neurodegenerative Diseases.International journal of molecular sciences · 2022
    Review
  12. NovelFrontiers in cellular neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Selva Baltan *Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue/NC30, Cleveland, OH, 44195, USA.
Safdar S Jawaid *Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue/NC30, Cleveland, OH, 44195, USA.
Anthony M ChomykDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue/NC30, Cleveland, OH, 44195, USA.
Grahame J KiddDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue/NC30, Cleveland, OH, 44195, USA.
Jacqueline ChenDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue/NC30, Cleveland, OH, 44195, USA.
Harsha D BattapadyDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue/NC30, Cleveland, OH, 44195, USA.
Ricky ChanCleveland Institute for Computational Biology, Cleveland, OH, 44106, USA.
Ranjan DuttaDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue/NC30, Cleveland, OH, 44195, USA.
Bruce D TrappDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue/NC30, Cleveland, OH, 44195, USA. trappb@ccf.org.ORCID 0000-0001-6682-3737
Cleveland Clinic Lerner College of Medicine · USCleveland Clinic · USOregon Health & Science University · US

Funding

Pathogenesis of Neurological Disability in Primary Diseases of MyelinR35NS097303 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI TRAPP, BRUCE D · 2017 to 2024
$6.9M
Vulnerability of Aging White Matter to IschemiaR01AG033720 · NIA · UNIVERSITY OF WASHINGTON · PI BALTAN, SELVA · 2010 to 2021
$2.7M
MicroRNAs as critical regulators of remyelination in Multiple SclerosisR01NS096148 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI DUTTA, RANJAN · 2016 to 2020
$1.7M
NIA NIH HHS R01 AG033720NINDS NIH HHS R01 NS096148NINDS NIH HHS R35NS09730NINDS NIH HHS R35 NS097303
6 · The paper itself

Abstract

Cognitive dysfunction occurs in greater than 50% of individuals with multiple sclerosis (MS). Hippocampal demyelination is a prominent feature of postmortem MS brains and hippocampal atrophy correlates with cognitive decline in MS patients. Cellular and molecular mechanisms responsible for neuronal dysfunction in demyelinated hippocampi are not fully understood. Here we investigate a mouse model of hippocampal demyelination where twelve weeks of treatment with the oligodendrocyte toxin, cuprizone, demyelinates over 90% of the hippocampus and causes decreased memory/learning. Long-term potentiation (LTP) of hippocampal CA1 pyramidal neurons is considered to be a major cellular readout of learning and memory in the mammalian brain. In acute slices, we establish that hippocampal demyelination abolishes LTP and excitatory post-synaptic potentials of CA1 neurons, while pre-synaptic function of Schaeffer collateral fibers is preserved. Demyelination also reduced Ca

Indexed as

AnimalsAstrocytesCognitive DysfunctionCuprizoneDemyelinating DiseasesDendritic SpinesDisease Models, AnimalHippocampusLong-Term PotentiationMagnetic Resonance ImagingMaleMiceMice, Inbred C57BLMicroscopy, ElectronMultiple SclerosisNeuronsCuprizoneDendritic spinesHippocampal demyelinationLong-term potentiation (LTP)Transcript profiling

Identifiers

PMID33648591
PMCPMC7923530
OpenAlexW3133813077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.